A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours
Clinical trial NCT01876771 · SUSPENDED
Trial details
- NCT number
- NCT01876771
- Sponsor
- AHS Cancer Control Alberta
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-29
- Primary completion
- 2042-12-01
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.